The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials.
 
Alessio Cortellini
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; IQvia; MSD Oncology; OncoC4
Speakers' Bureau - AstraZeneca; Eisai
 
Valentina Santo
No Relationships to Disclose
 
Leonardo Brunetti
No Relationships to Disclose
 
Davide Mangani
No Relationships to Disclose
 
Ana C Anderson
No Relationships to Disclose
 
Bruno Vincenzi
No Relationships to Disclose
 
Giuseppe Tonini
Consulting or Advisory Role - Italfarmaco; Molteni Farmaceutici; Novartis; Pierre Fabre; Roche
Research Funding - Novartis (Inst); PharmaMar (Inst)
 
Kazuki Takada
No Relationships to Disclose
 
Abdul Rafeh Naqash
Honoraria - NGM Biopharmaceuticals
Consulting or Advisory Role - foundation me
Travel, Accommodations, Expenses - American Society for Radiation Oncology; ASCO; Binacea; Foundation Medicine; Jazz Pharmaceuticals (Inst); Society for Immunotherapy of Cancer
 
Biagio Ricciuti
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Guidepoint Inc; Regeneron
 
David James Pinato
Honoraria - Avammune; Bristol-Myers Squibb; Da Volterra; Lift Biosciences; Mursla Bio; Roche/Genentech; Starpharma
Consulting or Advisory Role - AstraZeneca; Da Volterra; EISAI; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley